Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Recurrent Platinum Resistant Ovarian Cancer
View Full LandscapeTarget Indication
Recurrent Platinum Resistant Ovarian Cancer
Clinical Trial
NCT02889900Last updated: 1/10/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Irritable Bowel Syndrome With Constipation (IBS-C)
Muscle Invasive Bladder Cancer
Asthma, Exercise-Induced
Affective Psychosis, Bipolar
Carcinoma, Non-Small-Cell Lung